-
patientregistry.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Inpatient-Weighted.pdf
September 26, 2023 - Percent
01: General practice 3,677 0.04 3,677 0.04
02: General surgery 31,657 0.33 35,334 0.37
03: Allergy
-
talkingquality.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Inpatient-Weighted.pdf
September 26, 2023 - Percent
01: General practice 3,677 0.04 3,677 0.04
02: General surgery 31,657 0.33 35,334 0.37
03: Allergy
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Inpatient-Weighted.pdf
September 26, 2023 - Percent
01: General practice 3,677 0.04 3,677 0.04
02: General surgery 31,657 0.33 35,334 0.37
03: Allergy
-
cahps.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Inpatient-Weighted.pdf
September 26, 2023 - Percent
01: General practice 3,677 0.04 3,677 0.04
02: General surgery 31,657 0.33 35,334 0.37
03: Allergy
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Inpatient-Weighted.pdf
September 26, 2023 - Percent
01: General practice 3,677 0.04 3,677 0.04
02: General surgery 31,657 0.33 35,334 0.37
03: Allergy
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Providers are also
required to "maintain active
medication list" and "maintain
active medication allergy
-
effectivehealthcare.ahrq.gov/products/smoking-pregnancy-infants/research-protocol
March 08, 2013 - [Perinatal exposure to tobacco and respiratory and allergy symptoms in first years of life].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
April 01, 2020 - randomised controlled trial to improve
maternal health during pregnancy and prevent infant
eczema and allergy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
March 11, 2013 - [Perinatal exposure to tobacco and respiratory and allergy symptoms in first
years of life].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - number of
recurrences, comorbidities,
history of complications of
acute otitis media,
antibiotic allergy
-
effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - number of
recurrences, comorbidities,
history of complications of
acute otitis media,
antibiotic allergy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - number of
recurrences, comorbidities,
history of complications of
acute otitis media,
antibiotic allergy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - number of
recurrences, comorbidities,
history of complications of
acute otitis media,
antibiotic allergy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
April 01, 2020 - randomised controlled trial to improve
maternal health during pregnancy and prevent infant
eczema and allergy
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
March 11, 2013 - [Perinatal exposure to tobacco and respiratory and allergy symptoms in first
years of life].
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/quality-patient-safety/patientsafetyculture/2018mosopsdatabasereport-part1.pdf
April 01, 2018 - Specialty
Number of
Medical
Offices Percent Specialty
Number of
Medical
Offices Percent
Allergy
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs018831-czaja-final-report-2013.pdf
January 01, 2013 - Finally, participants completed a very similar criterion task (2) involving OTC allergy
medications.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Providers are also
required to "maintain active
medication list" and "maintain
active medication allergy
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
March 02, 2020 - Prevention and 1 federal partner representing the National Institutes of Health, National Institute of Allergy
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkWNoq6KQb3SoZ54gscLCQ
July 25, 2016 - Prevention, and 1 federal partner each representing
the National Institutes of Health, National Institute
of Allergy